I look forward to continuing to collaborate with M-PED, who continues to pursue innovative solutions to conditions that affect children. MC3 brings experience in product development and commercialization, which can help the innovators' device concepts reach the market.
To date, 5 children with tracheobroncomalasia have been treated at the University of Michigan CS Mott Children's Hospital with 3D-printed tracheal splints under FDA Emergency Clearance. The team, led by Dr. Scott Hollister and Dr. Glenn Green, are applying for FDA Investigational Device Exemption (IDE) to treat an additional 10 patients with this technology.
Michigan Pediatric Device Consortium (M-PED)
400 N Ingalls Building
Ann Arbor, MI 48109
U-M Medical School |
U-M Gateway |
© Copyright 2017
Regents of the University of Michigan | Disclaimer | Privacy